Patent Assignment
Reel/Frame 024187/0161
Assignment of Assignor's Interest
Recorded: 2010-04-05
Pages: 18
Assignors
ROSKAMP FOUNDATION IRREVOCABLE TRUST (D/B/A ROSKAMP INSTITUTE)
Executed: 2010-01-29
ROSKAMP RESEARCH LLC
Executed: 2010-01-29
ARCHER PHARMACEUTICALS, INC.
Executed: 2010-01-29
Assignee
ALZHEIMER'S INSTITUTE OF AMERICA, INC.
7837 PARALLEL PARKWAY, KANSAS CITY, MISSOURI, 66112
Covered Property
(1)
Methods and compounds for disruption of CD40R/CD40L signaling in the treatment of Alzheimer's disease
Application:
11/523,468 →
Publication:
US 2007/0160615